DPI-289 (Adamis Pharmaceuticals)

N/A

Report date: 2025/03/18 18:20:21
NME

Base Information

Drug NameDPI-289 (Adamis Pharmaceuticals)
Drug Alias NameDPI-289
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdamis Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesDMK Pharmaceuticals Corp
Inactive CompaniesAdamis Pharmaceuticals Corp
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A